108 related articles for article (PubMed ID: 10632501)
21. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.
Sivridis E; Giatromanolaki A
J Clin Pathol; 2004 Aug; 57(8):840-4. PubMed ID: 15280405
[TBL] [Abstract][Full Text] [Related]
22. Atypical squamous cells in the urine revealing endometrioid adenocarcinoma of the endometrium with squamous cell differentiation: a case report.
Wang Y; Otis CN; Florence RR
Diagn Cytopathol; 2015 Jan; 43(1):49-52. PubMed ID: 24535963
[TBL] [Abstract][Full Text] [Related]
23. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome.
Elit LM; Pond G; Seow H
Obstet Gynecol; 2015 Jun; 125(6):1497-1498. PubMed ID: 26000530
[No Abstract] [Full Text] [Related]
24. The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.
Nishimura S; Ito YM; Tsuda H; Ohnishi Y; Kataoka F; Nomura H; Chiyoda T; Suzuki A; Susumu N; Aoki D; Hatae M
Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):67-72. PubMed ID: 19815329
[TBL] [Abstract][Full Text] [Related]
25. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
26. Complete Histologic Regression of Endometrioid Adenocarcinoma on Endometrial Biopsy After Progestin Treatment Does Not Guarantee the Regression of an Invasive Carcinoma Within the Myometrium.
Park JY; Park JY; Nam JH; Kim KR
Int J Gynecol Pathol; 2019 Jan; 38(1):66-70. PubMed ID: 29257040
[TBL] [Abstract][Full Text] [Related]
27. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
Sivridis E; Giatromanolaki A; Koukourakis MI; Georgiou L; Anastasiadis P
Histopathology; 2002 Jan; 40(1):92-100. PubMed ID: 11903603
[TBL] [Abstract][Full Text] [Related]
28. Interpretation of diffuse Cdx2 expression in endometrioid adenocarcinoma in the absence of morules.
Wani Y
Histopathology; 2009 Mar; 54(4):495-7. PubMed ID: 19309406
[No Abstract] [Full Text] [Related]
29. Clinicopathologic analysis of the prognostic factors in women with coexistence of endometrioid adenocarcinoma in the endometrium and ovary.
Nishimura N; Hachisuga T; Yokoyama M; Iwasaka T; Kawarabayashi T
J Obstet Gynaecol Res; 2005 Apr; 31(2):120-6. PubMed ID: 15771637
[TBL] [Abstract][Full Text] [Related]
30. Case report: Endometrial carcinoma after endometrial resection for menorrhagia.
Archer DF
J Womens Health; 1998 May; 7(4):473-5. PubMed ID: 9611708
[No Abstract] [Full Text] [Related]
31. MAGE-A4 and MAGE-A1 Immunohistochemical Expression in High-grade Endometrial Cancer.
Srdelić S; Kuzmić-Prusac I; Spagnoli GC; Juretić A; Čapkun V
Int J Gynecol Pathol; 2019 Jan; 38(1):59-65. PubMed ID: 29140883
[TBL] [Abstract][Full Text] [Related]
32. Epithelial-to-mesenchymal transition in endometrioid adenocarcinoma of the endometrium.
Stewart CJ
Hum Pathol; 2013 Sep; 44(9):1956-7. PubMed ID: 23969094
[No Abstract] [Full Text] [Related]
33. Occurrence of endometrial cancer six years after treatment with thermal balloon ablation (Thermachoice): first case report.
Le Marrec A; Lavoue V; Morcel K; Duval H; Bauville E; Foucher F; Leveque J
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):219-20. PubMed ID: 20304551
[No Abstract] [Full Text] [Related]
34. How often does cervical involvement upstage patients with non-myoinvasive (otherwise stage 1A) endometrioid adenocarcinoma of the endometrium?
Fadare O; Desrosiers L; Xiao ZF; Wang SA
Virchows Arch; 2007 May; 450(5):601-2. PubMed ID: 17406893
[No Abstract] [Full Text] [Related]
35. Epithelial-to-mesenchymal transition in endometrioid adenocarcinoma of the endometrium--reply.
Mozos A; Prat J
Hum Pathol; 2013 Sep; 44(9):1957. PubMed ID: 23969096
[No Abstract] [Full Text] [Related]
36. Prognostic factors in stage II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium. P. Mhawech-Fauceglia, R.F. Herrmann, J. Kesterson, I. Izevbaye, S. Lele, K. Odunsi. Eur J Surg Oncol 2010 Dec;36(12):1195-201.
Geels YP; Massuger LF; Pijnenborg JM
Eur J Surg Oncol; 2011 Aug; 37(8):734-5; author reply 736. PubMed ID: 21680132
[No Abstract] [Full Text] [Related]
37. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
[TBL] [Abstract][Full Text] [Related]
38. Expression of p53 in imprint smears of endometrial carcinoma.
Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
[TBL] [Abstract][Full Text] [Related]
39. Tumor-infiltrating dendritic cells may be used as clinicopathologic prognostic factors in endometrial carcinoma.
Lijun Z; Xin Z; Danhua S; Xiaoping L; Jianliu W; Huilan W; Lihui W
Int J Gynecol Cancer; 2012 Jun; 22(5):836-41. PubMed ID: 22617481
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan.
Kuwabara Y; Susumu N; Banno K; Hirao T; Kawaguchi M; Yamagami W; Suzuki N; Aoki D; Nozawa S
Jpn J Clin Oncol; 2005 Jan; 35(1):23-7. PubMed ID: 15681600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
